Senior Counsel Katie Catanese was quoted in a Law360 article, “Del. Justices Urged To Remand S. China Livestock Case,” when she argued before the Delaware Supreme Court that a lower court judge had erred when he tossed claims in a summary judgment motion against the former executive of a failed Chinese livestock company.
Catanese represents the court-appointed receiver for Southern China Livestock Inc., who is suing Shu Kaneko, a former executive and director at the company, for breach of fiduciary duty, alleging that Kaneko stole more than $2.35 million from investors before the newly formed company “went dark” and stopped reporting to the U.S. Securities and Exchange Commission.
She told the three-judge panel that the lower court ruling incorrectly rejected arguments that Southern China Livestock received any value for impermissibly taken shares of the company. Those shares were allegedly returned to secure the release of fraudulent transfer claims and other allegations against Kaneko.
“We ask that Kaneko not be able to use the release that he’s attempting to use in this case as a cloak to avoid liability here,” she said. “We believe there are strong issues of fact regarding the fraudulent transfers and, most importantly, the value of the consideration or the alleged consideration supporting the release.”
Catanese represents the court-appointed receiver for Southern China Livestock Inc., who is suing Shu Kaneko, a former executive and director at the company, for breach of fiduciary duty, alleging that Kaneko stole more than $2.35 million from investors before the newly formed company “went dark” and stopped reporting to the U.S. Securities and Exchange Commission.
She told the three-judge panel that the lower court ruling incorrectly rejected arguments that Southern China Livestock received any value for impermissibly taken shares of the company. Those shares were allegedly returned to secure the release of fraudulent transfer claims and other allegations against Kaneko.
“We ask that Kaneko not be able to use the release that he’s attempting to use in this case as a cloak to avoid liability here,” she said. “We believe there are strong issues of fact regarding the fraudulent transfers and, most importantly, the value of the consideration or the alleged consideration supporting the release.”
People
Related News
25 July 2024
In the News
Donald Schroeder on Groff – ‘Supreme Court decision is inviting a more fact-based analysis’
Foley & Lardner LLP partner Donald Schroeder assessed the impact of the U.S. Supreme Court’s 2023 decision in a religious accommodation case as it returns to the district court in the Law360 article, “A Year After High Court Spotlight, Groff Case Still A Bellwether.”
24 July 2024
In the News
Louis Lehot Featured in Q&A on How Startups Can Prepare for IPO
Foley & Lardner LLP partner Louis Lehot features in the Q&A, "How startups can get in top shape for an IPO, according to Silicon Valley lawyer Louis Lehot," part of Business Insider's Road to IPO' series.
24 July 2024
In the News
Courtenay Brinckerhoff on Patent Cap in Drug Pricing – ‘Hard to predict if this will make a difference’
Foley & Lardner LLP partner Courtenay Brinckerhoff discussed a recent bill passed in the U.S. Senate aimed at lowering drug prices by limiting the number of patents that can be asserted in cases over biosimilars in the Law360 article, “Patent Cap In Drug Pricing Bill Seen As Having Muted Effect.”